Yield and safety of different biopsy types in interstitial lung disease: a systematic review and meta-analysis
Clinical Snapshot
PICO Framework
| P — Population | Patients with interstitial lung disease (ILD), particularly fibrotic ILD |
| I — Intervention | Transbronchial lung cryobiopsy (TBLC) and transbronchial forceps biopsy (TBB) |
| C — Comparator | Surgical lung biopsy (SLB) |
| O — Outcomes | Multidisciplinary diagnostic yield and safety complications |
Bottom Line
This comprehensive meta-analysis of 143 studies demonstrates that transbronchial lung cryobiopsy (TBLC) achieves equivalent diagnostic yield to surgical lung biopsy (SLB) in interstitial lung disease, with both methods showing 85-90% multidisciplinary yield. Traditional transbronchial forceps biopsy shows significantly lower yield (35%), particularly poor in fibrotic disease (12.5%). TBLC complications are more frequent than forceps biopsy but generally less severe than surgical biopsy. The findings support using either TBLC or SLB as first-line diagnostic tools in fibrotic ILD, with choice based on patient factors, local expertise, and shared decision-making. This evidence challenges the traditional surgical-first approach and supports broader adoption of cryobiopsy in appropriate centres.
Key Findings
P Value: Not reported
Effect Size: TBLC: 84.3%, SLB: 88.6%, TBB: 35.3% (all ILD); TBLC: 87.6%, SLB: 87.3% (fibrotic ILD)
Primary Outcome: Multidisciplinary diagnostic yield
Nnt Or Sensitivity: Equivalent diagnostic yield between TBLC and SLB (85-90% ceiling effect)
Confidence Interval: TBLC: 81.7-86.5%, SLB: 83.4-92.3% (all ILD); TBLC: 83.5-90.7%, SLB: 80.5-92.0% (fibrotic ILD)
Clinical Application
TBLC offers less invasive alternative to SLB with equivalent diagnostic yield Relevant to Australian respiratory physicians; TBLC availability may vary across centres; aligns with TSANZ guidelines for ILD management Patients with ILD requiring tissue diagnosis, particularly those with fibrotic patterns
Abstract
BACKGROUND: Lung biopsy remains an important consideration in the management of interstitial lung disease (ILD). Transbronchial lung cryobiopsy (TBLC) offers an alternative to traditional surgical lung biopsy (SLB) and transbronchial forceps biopsy (TBB); however, up-to-date comparisons between these methods in ILD, particularly fibrotic ILD, remain limited. METHODS: A comprehensive literature search of Medline, Embase and Evidence-Based Medicine Reviews was performed for studies published between January 2000 and September 2025 to identify all citations reporting yield and complications of the three main lung biopsy methods for ILD. RESULTS: A total of 143 studies were included. Pooled multidisciplinary yield (following multidisciplinary discussion) in TBB, TBLC and SLB was 35.3% (95% CI 21.3-52.5), 84.3% (95% CI 81.7-86.5) and 88.6% (95% CI 83.4-92.3), respectively. For fibrotic ILD, the multidisciplinary yield was 12.5% (only one eligible study), 87.6% (95% CI 83.5-90.7) and 87.3% (95%CI 80.5-92.0), respectively. Meta-regression showed an increasing multidisciplinary yield of TBLC with more recent years of patient recruitment and an increasing percentage of fibrotic ILD in each study. The multidisciplinary yield of both TBLC and SLB was 85-90%, suggesting a biopsy "ceiling effect". All evaluated complications were more frequent in TBLC compared to TBB and some were more frequent in SLB compared to TBLC. Several complications were more frequent in fibrotic ILD compared to all ILD. CONCLUSIONS: The multidisciplinary yield of TBLC and SLB is equivalent, with both offering an acceptable safety profile. TBB has low yield, particularly in fibrotic ILD. These findings support using either TBLC or SLB as an initial diagnostic tool in fibrotic ILD, mainly based on patient-physician shared decision-making.
References
- 1.Mor, E., Belmonte, L. A., Degrassi, M., Marinescu, D. C., & Ryerson, C. J. (2026). Yield and safety of different biopsy types in interstitial lung disease: a systematic review and meta-analysis. European Respiratory Review, Article 14695. https://doi.org/10.1111/resp.14695
Related Research
Sleep medicine
Concordance of wearable device sleep metrics with patient-reported sleep quality: A systematic review
3 Aug 2026
Bioelectrochemistry (Amsterdam, Netherlands)
From data to diagnosis: A comprehensive review of machine learning-driven wearable sensors in healthcare.
2 Aug 2026
JMIR mHealth and uHealth
Wearable Devices for Monitoring and Management of Comorbid Obstructive Sleep Apnea and Hypertension: Scoping Review
1 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service